---
search:
  exclude: true
---

# RE: Synagis Questions

<div class="WordSection1">

**<span style="color:black">From:<span style="mso-tab-count:1">                                            
</span></span>**<span style="color:black">OH\_MCD\_PBM\_clinical</span>

**<span style="color:black">Sent:<span style="mso-tab-count:1">                                              
</span></span>**<span style="color:black">Wednesday, February 1, 2023
3:09 PM</span>

**<span style="color:black">To:<span style="mso-tab-count:1">                                                 
</span></span>**<span style="color:black">Roach, Cassandra</span>

**<span style="color:black">Cc:<span style="mso-tab-count:1">                                                  
</span></span>**<span style="color:black">Haas, Brandon; Collingwood,
Justin; Carpenter, Rachel; OH SPBM PA Pharmacist</span>

**<span style="color:black">Subject:<span style="mso-tab-count:1">                                        
</span></span>**<span style="color:black">RE: Synagis questions </span>

 

**<span style="color:black;
mso-ligatures:none">From:</span>**<span style="color:black;mso-ligatures:
none"> Doughty, Yana \<<Yana.Doughty@medicaid.ohio.gov>\>  
**Sent:** Wednesday, February 1, 2023 4:01 PM  
**To:** Kijowski, Scott \<<Scott.Kijowski@medicaid.ohio.gov>\>  
**Cc:** MCD MedicaidSPBM \<<MedicaidSPBM@medicaid.ohio.gov>\>; Eckard,
Sean \<<Sean.Eckard@medicaid.ohio.gov>\>; Chenevey, Andrew
\<<Andrew.Chenevey@medicaid.ohio.gov>\>; Nestleroth, Meghan
\<<Meghan.Nestleroth@medicaid.ohio.gov>\>  
**Subject:** RE: Synagis questions from GW
</span><span style="mso-ligatures:
none"></span>

<span style="mso-ligatures:none"> </span>

<span style="mso-ligatures:none">Hi Scott,</span>

<span style="mso-ligatures:none"> </span>

<span style="mso-ligatures:none">See below for responses. Let me know if
there are any further questions.</span>

<span style="mso-ligatures:none"> </span>

<span style="mso-ligatures:none">Thanks,</span>

<span style="mso-ligatures:none"> </span>

<span style="mso-ligatures:none">Yana</span>

<span style="mso-ligatures:none"> </span>

**<span style="mso-ligatures:
none">From:</span>**<span style="mso-ligatures:none"> Kijowski, Scott
\<<Scott.Kijowski@medicaid.ohio.gov>\>  
**Sent:** Wednesday, February 1, 2023 3:05 PM  
**To:** Doughty, Yana \<<Yana.Doughty@medicaid.ohio.gov>\>  
**Subject:** Synagis questions from GW </span>

<span style="mso-ligatures:none"> </span>

<span style="color:black;
mso-ligatures:none">Good afternoon\! </span><span style="mso-ligatures:
none"></span>

<span style="color:black;
mso-ligatures:none"> </span><span style="mso-ligatures:none"></span>

<span style="color:black;
mso-ligatures:none">Some valid concerns have been raised from the PA
pharmacists regarding the early end to Synagis season by ODM. We were
hoping that you (clinical team) or ODM could provide us guidance with
the following:  </span><span style="mso-ligatures:none"></span>

<span style="color:black;
mso-ligatures:none"> </span><span style="mso-ligatures:none"></span>

1.  <span style="mso-fareast-font-family:&quot;Times New Roman&quot;;
         mso-ligatures:none">In the email chain below, it was stated
    (regarding cases being approved past 2/15/23): “Only very few,
    severely at risk patients with extenuating circumstances should be
    allowed beyond that.” How are we to appropriately determine who is
    severely at risk as Synagis requests are for those that generally
    have complex medical histories?
     </span><span style="mso-fareast-font-family:&quot;Times New Roman&quot;;
         color:red;mso-ligatures:none">I anticipate most PAs for this
    will lead to denial. Some of these may in turn become appeals. These
    should be completed with a medical director’s input due to the
    complex clinical nature of the situation.
    </span><span style="mso-fareast-font-family:&quot;Times New Roman&quot;;
         mso-ligatures:none"></span>
2.  <span style="mso-fareast-font-family:&quot;Times New Roman&quot;;
         mso-ligatures:none">We anticipate we will see many of these on
    Appeals. Should these appeals be evaluated in consultation with the
    Gainwell medical director?
     </span><span style="mso-fareast-font-family:&quot;Times New Roman&quot;;
         color:red;mso-ligatures:none">Yes.
    </span><span style="mso-fareast-font-family:
         &quot;Times New Roman&quot;;mso-ligatures:none"></span>
3.  <span style="mso-fareast-font-family:&quot;Times New Roman&quot;;
         mso-ligatures:none">Has ODM sent communication to hospitals,
    prescribers and pharmacies stating that the season is being termed
    early? If not, when will this communication be given?
     </span><span style="mso-fareast-font-family:
         &quot;Times New Roman&quot;;color:red;mso-ligatures:none">ODM
    sent communication to each managed care plan regarding this
    information. ODM is also a member of a listserv which includes all
    of the children’s hospitals across the state of Ohio and their lab
    directors. This information was disseminated via this listserv. Both
    SPBM and CHC were looped into this as well.
    </span><span style="mso-fareast-font-family:&quot;Times New Roman&quot;;mso-ligatures:none"></span>
4.  <span style="mso-fareast-font-family:&quot;Times New Roman&quot;;
         mso-ligatures:none">Can specific references be given to us so
    that we may point prescribers to the data ODM has reviewed to make
    this decision, or should we direct them to the CDC website (shown
    below)? We anticipate providers will want this information during
    peer to peers.
     </span><span style="mso-fareast-font-family:&quot;Times New Roman&quot;;color:red;mso-ligatures:
         none">CDC website is appropriate to reference. The listserv ODM
    is a member of includes weekly positivity rate updates from each
    individual hospital.
    </span><span style="mso-fareast-font-family:&quot;Times New Roman&quot;;
         mso-ligatures:none"></span>
5.  <span style="mso-fareast-font-family:&quot;Times New Roman&quot;;
         mso-ligatures:none">What denial language would ODM like us to
    use when denying these cases beyond
    2/15/2023? </span><span style="mso-fareast-font-family:
         &quot;Times New Roman&quot;;color:red;mso-ligatures:none">The
    Synagis season has completed on 2/15/2023 in response to decreased
    and sustained low RSV positivity rates.
    </span><span style="mso-fareast-font-family:&quot;Times New Roman&quot;;
         mso-ligatures:none"></span>

<span style="color:black;
mso-ligatures:none"> </span><span style="mso-ligatures:none"></span>

<span style="color:black;
mso-ligatures:none">Thank
you, </span><span style="mso-ligatures:none"></span>

<span style="color:black;
mso-ligatures:none"> </span><span style="mso-ligatures:none"></span>

<span style="font-size:10.5pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;mso-ligatures:none">Cassandra
Roach, PharmD,
RPh</span><span style="font-size:10.5pt;font-family:&quot;Segoe UI&quot;,sans-serif;
color:#201F1E;mso-ligatures:none"> </span><span style="mso-ligatures:none"></span>

<span style="font-size:12.0pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none">Prior
Authorization
Pharmacist</span><span style="color:#201F1E;mso-ligatures:none"> </span><span style="mso-ligatures:none"></span>

<span style="font-size:12.0pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none">Ohio
SPBM</span><span style="color:#201F1E;mso-ligatures:none"> </span><span style="mso-ligatures:
none"></span>

<div>

<div style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">

**<span style="mso-ligatures:
none">From:</span>**<span style="mso-ligatures:none"> Roach, Cassandra
\<<cassandra.roach@gainwelltechnologies.com>\>  
**Sent:** Wednesday, February 1, 2023 1:52 PM  
**To:** OH\_MCD\_PBM\_clinical
\<<OH_MCD_PBM_clinical@gainwelltechnologies.com>\>  
**Cc:** Haas, Brandon \<<brandon.haas@gainwelltechnologies.com>\>;
Collingwood, Justin \<<justin.collingwood@gainwelltechnologies.com>\>;
Carpenter, Rachel \<<rachel.carpenter@gainwelltechnologies.com>\>; OH
SPBM PA Pharmacist \<<OHSPBMPAPharmacist@mygainwell.onmicrosoft.com>\>  
**Subject:** Synagis questions  
**Importance:** High</span>

</div>

</div>

 

Good afternoon\!

 

Some valid concerns have been raised from the PA pharmacists regarding
the early end to Synagis season by ODM. We were hoping that you
(clinical team) or ODM could provide us guidance with the following:

 

1.  <span style="mso-fareast-font-family:&quot;Times New Roman&quot;">In
    the email chain below, it was stated (regarding cases being approved
    past 2/15/23): “Only very few, severely at risk patients with
    extenuating circumstances should be allowed beyond that.” How are we
    to appropriately determine who is severely at risk as Synagis
    requests are for those that generally have complex medical
    histories? </span>
2.  <span style="mso-fareast-font-family:&quot;Times New Roman&quot;">We
    anticipate we will see many of these on Appeals. Should these
    appeals be evaluated in consultation with the Gainwell medical
    director? </span>
3.  <span style="mso-fareast-font-family:&quot;Times New Roman&quot;">Has
    ODM sent communication to hospitals, prescribers and pharmacies
    stating that the season is being termed early? If not, when will
    this communication be given? </span>
4.  <span style="mso-fareast-font-family:&quot;Times New Roman&quot;">Can
    specific references be given to us so that we may point prescribers
    to the data ODM has reviewed to make this decision, or should we
    direct them to the CDC website (shown below)? We anticipate
    providers will want this information during peer to peers. </span>
5.  <span style="mso-fareast-font-family:&quot;Times New Roman&quot;">What
    denial language would ODM like us to use when denying these cases
    beyond 2/15/2023?</span>

 

Thank you,

 

<div>

<span style="font-size:10.5pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;mso-ligatures:none">Cassandra
Roach, PharmD,
RPh</span><span style="font-size:10.5pt;font-family:&quot;Segoe UI&quot;,sans-serif;
color:#201F1E;mso-ligatures:none"></span>

<span style="font-size:12.0pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none">Prior
Authorization
Pharmacist</span><span style="color:#201F1E;mso-ligatures:none"></span>

<span style="font-size:12.0pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none">Ohio
SPBM</span><span style="color:#201F1E;mso-ligatures:none"></span>

<span style="font-size:12.0pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none"> </span><span style="color:#201F1E;mso-ligatures:none"></span>

<span style="font-size:12.0pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none">M
1.419.957.0016</span><span style="color:#201F1E;mso-ligatures:none"></span>

<span style="font-size:12.0pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none">T
+0.000.000.0000</span><span style="color:#201F1E;mso-ligatures:none"></span>

<span style="font-size:10.5pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;mso-ligatures:none"><Cassandra.Roach@gainwelltechnologies.com></span><span style="font-size:10.5pt;font-family:&quot;Segoe UI&quot;,sans-serif;color:#201F1E;
mso-ligatures:none"></span>

<span style="font-size:12.0pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none"> </span><span style="color:#201F1E;mso-ligatures:none"></span>

<span style="font-size:12.0pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none">Gainwell
Technologies</span><span style="color:#201F1E;mso-ligatures:none"></span>

<span style="font-size:12.0pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none">5475
Rings RD</span><span style="color:#201F1E;mso-ligatures:none"></span>

<span style="font-size:12.0pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none">Atrium
II North Tower, Suite
125</span><span style="color:#201F1E;mso-ligatures:none"></span>

<span style="font-size:12.0pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none">Dublin,
OH
43017-7565</span><span style="color:#201F1E;mso-ligatures:none"></span>

<span style="font-size:12.0pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none"> </span><span style="color:#201F1E;mso-ligatures:none"></span>

<span style="font-size:12.0pt;
font-family:&quot;Calibri Light&quot;,sans-serif;color:#201F1E;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none">Gainwelltechnologies.com</span><span style="color:#201F1E;mso-ligatures:none"></span>

<span style="font-family:&quot;Arial&quot;,sans-serif;
color:#201F1E;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0in;
padding:0in;mso-ligatures:none"> </span><span style="color:#201F1E;
mso-ligatures:none"></span>

<span style="color:#201F1E;
mso-ligatures:none"> </span><span style="color:black;mso-ligatures:none"><span class="image"></span></span><span style="mso-ligatures:none"></span>

</div>

 

 

<div>

<div style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">

**<span style="mso-ligatures:
none">From:</span>**<span style="mso-ligatures:none"> Vasavanont, Jim
\<<surasak.vasavanont@gainwelltechnologies.com>\>  
**Sent:** Wednesday, February 1, 2023 12:59 PM  
**To:** Haas, Brandon \<<brandon.haas@gainwelltechnologies.com>\>  
**Subject:** RE: Synagis Update</span>

</div>

</div>

 

Hello Brandon,

 

Thank you for the support. I understand that the direction is from the
top and need to implement ODM policy. Can you confirm if a new PA will
be required for after 02/16/2023 and if so for one dose approval or two
dose approval?

 

Thanks again.

 

Jim

 

<div>

<div style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">

**<span style="mso-ligatures:
none">From:</span>**<span style="mso-ligatures:none"> Haas, Brandon
\<<brandon.haas@gainwelltechnologies.com>\>  
**Sent:** Wednesday, February 1, 2023 11:04 AM  
**To:** Vasavanont, Jim
\<<surasak.vasavanont@gainwelltechnologies.com>\>  
**Subject:** RE: Synagis Update</span>

</div>

</div>

 

Hi Jim,

 

If you come upon any individual cases where you believe that it is
appropriate to continue, then document your reasoning very well with the
assumption that ODM will specifically question the decision later.

 

This isn’t a negotiable scenario.  We were directed in not-uncertain
terms to proceed as Denise shared below.  I would expect that ODM will
be sending a communication on this to providers, but I don’t have
specific information on that.

 

Thank you,

Brandon

 

<div>

**<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;
mso-ligatures:none">Brandon Haas,
PharmD</span>**<span style="font-family:
&quot;Arial&quot;,sans-serif;color:black;mso-ligatures:none">  
Pharmacist Supervisor – Prior Authorization</span>

<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;
mso-ligatures:none">OH Medicaid PBM</span>

<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;
mso-ligatures:none"></span>

 

<span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;
color:black;mso-ligatures:none">T: 614-721-1240</span>

[<span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-ligatures:none">Brandon.Haas@GainwellTechnologies.com</span>](mailto:Brandon.Haas@GainwellTechnologies.com)<span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;color:black;mso-ligatures:
none"></span>

**<span style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;
color:black;mso-ligatures:none"></span>**

 

**<span style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;
color:black;mso-ligatures:none">Gainwell Technologies
</span>**<span style="mso-ligatures:none"></span>

<span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;
mso-ligatures:none">5475 Rings Rd.</span><span style="font-size:10.5pt;
font-family:Roboto;background:white;mso-ligatures:none"></span>

<span style="font-size:10.5pt;font-family:Roboto;color:black;
background:white;mso-ligatures:none">Atrium II North Tower, Suite
125</span><span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-ligatures:none">  
Dublin, OH
43017-</span><span style="font-size:10.5pt;font-family:Roboto;
color:black;background:white;mso-ligatures:none">7565</span><span style="font-size:10.5pt;font-family:Roboto;background:white;mso-ligatures:none"></span>

<span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;
color:black;mso-ligatures:none"></span>

 

<span style="mso-ligatures:none"><span class="image"></span></span><span style="font-size:
10.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-ligatures:none"></span>

<span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;
color:black;mso-ligatures:none">gainwelltechnologies.com</span><span style="mso-ligatures:none"></span>

<span style="mso-ligatures:none"></span>

 

<span style="mso-ligatures:none">Out of Office Alert:  </span>

</div>

 

<div>

<div style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">

**<span style="mso-ligatures:
none">From:</span>**<span style="mso-ligatures:none"> Vasavanont, Jim
\<<surasak.vasavanont@gainwelltechnologies.com>\>  
**Sent:** Wednesday, February 1, 2023 11:18 AM  
**To:** Haas, Brandon \<<brandon.haas@gainwelltechnologies.com>\>  
**Subject:** RE: Synagis Update</span>

</div>

</div>

 

 

Good morning

Statically I probably agree, but implementation wise there will be a lot
people who will be upset if they think they can get their end of
February dose and are denied in addition to their march dose.

 

Additionally, there is nothing on the department of Medicaid for recent
communications.

 

Thank you

 

 

<span style="mso-ligatures:none"><span class="image"></span></span>

 

 

 

 

<span style="mso-ligatures:none"><span class="image"></span></span>

 

<div>

<div style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">

**<span style="mso-ligatures:
none">From:</span>**<span style="mso-ligatures:none"> Haas, Brandon
\<</span>[<span style="mso-ligatures:
none">brandon.haas@gainwelltechnologies.com</span>](mailto:brandon.haas@gainwelltechnologies.com)<span style="mso-ligatures:
none">\>  
**Sent:** Tuesday, January 31, 2023 4:58 PM  
**To:** OH SPBM PA Pharmacist
\<</span>[<span style="mso-ligatures:none">OHSPBMPAPharmacist@mygainwell.onmicrosoft.com</span>](mailto:OHSPBMPAPharmacist@mygainwell.onmicrosoft.com)<span style="mso-ligatures:none">\>  
**Subject:** FW: Synagis Update  
**Importance:** High</span>

</div>

</div>

 

ODM is ending Synagis season early on 2/15/2023.  Please see Denise’s
comments below regarding their expectations.

 

<div>

**<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;
mso-ligatures:none">Brandon Haas,
PharmD</span>**<span style="font-family:
&quot;Arial&quot;,sans-serif;color:black;mso-ligatures:none">  
Pharmacist Supervisor – Prior Authorization</span>

<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;
mso-ligatures:none">OH Medicaid PBM</span>

<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;
mso-ligatures:none"></span>

 

<span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;
color:black;mso-ligatures:none">T: 614-721-1240</span>

[<span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-ligatures:none">Brandon.Haas@GainwellTechnologies.com</span>](mailto:Brandon.Haas@GainwellTechnologies.com)<span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;color:black;mso-ligatures:
none"></span>

**<span style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;
color:black;mso-ligatures:none"></span>**

 

**<span style="font-size:14.0pt;font-family:&quot;Arial&quot;,sans-serif;
color:black;mso-ligatures:none">Gainwell Technologies
</span>**<span style="mso-ligatures:none"></span>

<span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;
mso-ligatures:none">5475 Rings Rd.</span><span style="font-size:10.5pt;
font-family:Roboto;background:white;mso-ligatures:none"></span>

<span style="font-size:10.5pt;font-family:Roboto;color:black;
background:white;mso-ligatures:none">Atrium II North Tower, Suite
125</span><span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-ligatures:none">  
Dublin, OH
43017-</span><span style="font-size:10.5pt;font-family:Roboto;
color:black;background:white;mso-ligatures:none">7565</span><span style="font-size:10.5pt;font-family:Roboto;background:white;mso-ligatures:none"></span>

<span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;
color:black;mso-ligatures:none"></span>

 

<span style="mso-ligatures:none"><span class="image"></span></span><span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;mso-ligatures:none"></span>

<span style="font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif;
color:black;mso-ligatures:none">gainwelltechnologies.com</span><span style="mso-ligatures:none"></span>

<span style="mso-ligatures:none"></span>

 

<span style="mso-ligatures:none">Out of Office Alert:  </span>

</div>

 

<div>

<div style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">

**<span style="mso-ligatures:
none">From:</span>**<span style="mso-ligatures:none"> Olusala, Denise
\<</span>[<span style="mso-ligatures:
none">denise.olusala@gainwelltechnologies.com</span>](mailto:denise.olusala@gainwelltechnologies.com)<span style="mso-ligatures:
none">\>  
**Sent:** Tuesday, January 31, 2023 3:29 PM  
**To:** Hartzell, Dave \<</span>[<span style="mso-ligatures:
none">david.hartzell@gainwelltechnologies.com</span>](mailto:david.hartzell@gainwelltechnologies.com)<span style="mso-ligatures:
none">\>; OH Supervisors and Sr. Techs
\<</span>[<span style="mso-ligatures:none">OHSupervisorsandSr.Techs@mygainwell.onmicrosoft.com</span>](mailto:OHSupervisorsandSr.Techs@mygainwell.onmicrosoft.com)<span style="mso-ligatures:none">\>  
**Cc:** Cornelius, Emily \<</span>[<span style="mso-ligatures:
none">emily.cornelius@gainwelltechnologies.com</span>](mailto:emily.cornelius@gainwelltechnologies.com)<span style="mso-ligatures:none">\>;
Collingwood, Justin
\<</span>[<span style="mso-ligatures:none">justin.collingwood@gainwelltechnologies.com</span>](mailto:justin.collingwood@gainwelltechnologies.com)<span style="mso-ligatures:none">\>;
Haas, Brandon \<</span>[<span style="mso-ligatures:
none">brandon.haas@gainwelltechnologies.com</span>](mailto:brandon.haas@gainwelltechnologies.com)<span style="mso-ligatures:
none">\>; Roach, Cassandra \<</span>[<span style="mso-ligatures:
none">cassandra.roach@gainwelltechnologies.com</span>](mailto:cassandra.roach@gainwelltechnologies.com)<span style="mso-ligatures:none">\>;
Hicks, Dusty \<</span>[<span style="mso-ligatures:
none">dusty.hicks@gainwelltechnologies.com</span>](mailto:dusty.hicks@gainwelltechnologies.com)<span style="mso-ligatures:
none">\>; Reinhart, Emily \<</span>[<span style="mso-ligatures:
none">emily.reinhart@gainwelltechnologies.com</span>](mailto:emily.reinhart@gainwelltechnologies.com)<span style="mso-ligatures:
none">\>; OH\_MCD\_PBM\_clinical
\<</span>[<span style="mso-ligatures:none">OH\_MCD\_PBM\_clinical@gainwelltechnologies.com</span>](mailto:OH_MCD_PBM_clinical@gainwelltechnologies.com)<span style="mso-ligatures:none">\>;
Banks, Aaron \<</span>[<span style="mso-ligatures:
none">aaron.banks@gainwelltechnologies.com</span>](mailto:aaron.banks@gainwelltechnologies.com)<span style="mso-ligatures:
none">\>; Holsapple, Rich
\<</span>[<span style="mso-ligatures:none">richard.holsapple@gainwelltechnologies.com</span>](mailto:richard.holsapple@gainwelltechnologies.com)<span style="mso-ligatures:none">\>  
**Subject:** RE: Synagis Update</span>

</div>

</div>

 

Hi Team,

  
This came out of the production meeting today with ODM.

ODM is ending Synagis season early on 2/15/2023.

Their expectation is that already approved Synagis PAs will have to be
closed out with end dates 2/15/2023 and new PAs should be end dated for
2/15/2023.

Only very few, severely at risk patients with extenuating circumstances
should be allowed beyond that.

 

 

**<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;
mso-ligatures:none">Denise Olusala,
PharmD</span>**<span style="font-family:
&quot;Arial&quot;,sans-serif;color:black;mso-ligatures:none">  
</span><span style="font-size:10.5pt;font-family:&quot;Arial&quot;,sans-serif;color:#333333;
background:white;mso-ligatures:none">PBM Call Center Services
Manager</span>

<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;
mso-ligatures:none">BPS Pharmacy Practice Operations</span>

<span style="font-size:4.0pt;font-family:&quot;Arial&quot;,sans-serif;
color:black;mso-ligatures:none">  </span>

[<span style="font-family:&quot;Arial&quot;,sans-serif;mso-ligatures:none">Denise.Olusala@gainwelltechnologies.com</span>](mailto:Denise.Olusala@gainwelltechnologies.com)<span style="font-family:&quot;Arial&quot;,sans-serif;mso-ligatures:none">
</span>

<span style="font-family:&quot;Arial&quot;,sans-serif;mso-ligatures:
none"></span>

 

**<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;
mso-ligatures:none">Gainwell Technologies </span>**

<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;
mso-ligatures:none">355 Ledgelawn Drive</span>

<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;
mso-ligatures:none">Conway, AR 72034</span>

<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;
mso-ligatures:none"><span class="image"></span></span><span style="mso-ligatures:none"></span>

 

 

 

<div>

<div style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">

**<span style="mso-ligatures:
none">From:</span>**<span style="mso-ligatures:none"> OH\_MCD\_PBM
\<</span>[<span style="mso-ligatures:
none">OH\_MCD\_PBM@gainwelltechnologies.com</span>](mailto:OH_MCD_PBM@gainwelltechnologies.com)<span style="mso-ligatures:
none">\>  
**Sent:** Tuesday, January 31, 2023 1:41 PM  
**To:** Olusala, Denise \<</span>[<span style="mso-ligatures:
none">denise.olusala@gainwelltechnologies.com</span>](mailto:denise.olusala@gainwelltechnologies.com)<span style="mso-ligatures:
none">\>; Hartzell, Dave \<</span>[<span style="mso-ligatures:
none">david.hartzell@gainwelltechnologies.com</span>](mailto:david.hartzell@gainwelltechnologies.com)<span style="mso-ligatures:
none">\>  
**Cc:** Cornelius, Emily \<</span>[<span style="mso-ligatures:
none">emily.cornelius@gainwelltechnologies.com</span>](mailto:emily.cornelius@gainwelltechnologies.com)<span style="mso-ligatures:none">\>;
Collingwood, Justin
\<</span>[<span style="mso-ligatures:none">justin.collingwood@gainwelltechnologies.com</span>](mailto:justin.collingwood@gainwelltechnologies.com)<span style="mso-ligatures:none">\>;
Haas, Brandon \<</span>[<span style="mso-ligatures:
none">brandon.haas@gainwelltechnologies.com</span>](mailto:brandon.haas@gainwelltechnologies.com)<span style="mso-ligatures:
none">\>; Roach, Cassandra \<</span>[<span style="mso-ligatures:
none">cassandra.roach@gainwelltechnologies.com</span>](mailto:cassandra.roach@gainwelltechnologies.com)<span style="mso-ligatures:none">\>;
Hicks, Dusty \<</span>[<span style="mso-ligatures:
none">dusty.hicks@gainwelltechnologies.com</span>](mailto:dusty.hicks@gainwelltechnologies.com)<span style="mso-ligatures:
none">\>; Reinhart, Emily \<</span>[<span style="mso-ligatures:
none">emily.reinhart@gainwelltechnologies.com</span>](mailto:emily.reinhart@gainwelltechnologies.com)<span style="mso-ligatures:
none">\>; OH\_MCD\_PBM\_clinical
\<</span>[<span style="mso-ligatures:none">OH\_MCD\_PBM\_clinical@gainwelltechnologies.com</span>](mailto:OH_MCD_PBM_clinical@gainwelltechnologies.com)<span style="mso-ligatures:none">\>  
**Subject:** FW: Synagis Update</span>

</div>

</div>

 

Please see update from ODM regarding Synagis season.

 

Thank you,

 

<div>

<div>

<div>

**<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;mso-ligatures:none">Ohio
SPBM</span>**

<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;mso-ligatures:none"></span>

 

<span style="color:black">[<span style="font-family:&quot;Arial&quot;,sans-serif;mso-ligatures:none">oh\_mcd\_pbm@gainwelltechnologies.com</span>](mailto:oh_mcd_pbm@gainwelltechnologies.com)</span><span style="font-family:&quot;Arial&quot;,sans-serif;color:black;mso-ligatures:none"></span>

<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;mso-ligatures:none"></span>

 

**<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none">Gainwell
Technologies </span>**<span style="font-family:&quot;Arial&quot;,sans-serif;
color:black;border:none windowtext 1.0pt;mso-border-alt:none windowtext 0in;
padding:0in;mso-ligatures:none"> </span><span style="font-family:&quot;Arial&quot;,sans-serif;
color:black;mso-ligatures:none"></span>

<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none">5475
Rings
Rd. </span><span style="font-family:&quot;Arial&quot;,sans-serif;color:black;
mso-ligatures:none"></span>

<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none">Atrium
II North Tower, Suite
125 </span><span style="font-family:&quot;Arial&quot;,sans-serif;
color:black;mso-ligatures:none"></span>

<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none">Dublin,
OH
43017-7565 </span><span style="font-family:&quot;Arial&quot;,sans-serif;color:black;
mso-ligatures:none"></span>

<span style="font-size:12.0pt;color:black;mso-ligatures:none"></span>

 

<span style="color:black;mso-ligatures:none"><span class="image"></span></span><span style="font-size:12.0pt;color:black;mso-ligatures:none"></span>

</div>

</div>

</div>

<span style="font-family:&quot;Arial&quot;,sans-serif;color:black;border:none windowtext 1.0pt;
mso-border-alt:none windowtext 0in;padding:0in;mso-ligatures:none">gainwelltechnologies.com</span>

 

 

<div>

<div style="border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">

**<span style="mso-ligatures:
none">From:</span>**<span style="mso-ligatures:none">
</span>[<span style="mso-ligatures:
none">ManagedCarePolicy@medicaid.ohio.gov</span>](mailto:ManagedCarePolicy@medicaid.ohio.gov)<span style="mso-ligatures:
none">
\<</span>[<span style="mso-ligatures:none">ManagedCarePolicy@medicaid.ohio.gov</span>](mailto:ManagedCarePolicy@medicaid.ohio.gov)<span style="mso-ligatures:none">\>  
**Sent:** Tuesday, January 31, 2023 2:36 PM  
**To:** AmeriHealth MCO \<</span>[<span style="mso-ligatures:
none">Amerihealth\_ohio@amerihealthcaritas.com</span>](mailto:Amerihealth_ohio@amerihealthcaritas.com)<span style="mso-ligatures:
none">\>;
</span>[<span style="mso-ligatures:none">AnthemBCBS\_OH\_RegSvcs@anthem.com</span>](mailto:AnthemBCBS_OH_RegSvcs@anthem.com)<span style="mso-ligatures:none">;
</span>[<span style="mso-ligatures:none">BUCKEYECOMPLIANCE@CENTENE.COM</span>](mailto:BUCKEYECOMPLIANCE@CENTENE.COM)<span style="mso-ligatures:none">;
</span>[<span style="mso-ligatures:none">ODJFS@CareSource.Com</span>](mailto:ODJFS@CareSource.Com)<span style="mso-ligatures:none">;
Humana MCO \<</span>[<span style="mso-ligatures:
none">humanahealthyhorizonsohio@humana.com</span>](mailto:humanahealthyhorizonsohio@humana.com)<span style="mso-ligatures:
none">\>;
</span>[<span style="mso-ligatures:none">MedicaidAmerihealth@medicaid.ohio.gov</span>](mailto:MedicaidAmerihealth@medicaid.ohio.gov)<span style="mso-ligatures:none">;
</span>[<span style="mso-ligatures:none">MedicaidAnthem@medicaid.ohio.gov</span>](mailto:MedicaidAnthem@medicaid.ohio.gov)<span style="mso-ligatures:none">;
</span>[<span style="mso-ligatures:none">MedicaidHumana@medicaid.ohio.gov</span>](mailto:MedicaidHumana@medicaid.ohio.gov)<span style="mso-ligatures:none">;
</span>[<span style="mso-ligatures:
none">MedicaidBuckeye@medicaid.ohio.gov</span>](mailto:MedicaidBuckeye@medicaid.ohio.gov)<span style="mso-ligatures:
none">;
</span>[<span style="mso-ligatures:none">MedicaidCareSource@medicaid.ohio.gov</span>](mailto:MedicaidCareSource@medicaid.ohio.gov)<span style="mso-ligatures:none">;
</span>[<span style="mso-ligatures:none">MedicaidMolina@medicaid.ohio.gov</span>](mailto:MedicaidMolina@medicaid.ohio.gov)<span style="mso-ligatures:none">;
</span>[<span style="mso-ligatures:none">MedicaidUnited@medicaid.ohio.gov</span>](mailto:MedicaidUnited@medicaid.ohio.gov)<span style="mso-ligatures:none">;
</span>[<span style="mso-ligatures:none">GovernmentContracts.MHO@MolinaHealthCare.Com</span>](mailto:GovernmentContracts.MHO@MolinaHealthCare.Com)<span style="mso-ligatures:none">;
</span>[<span style="mso-ligatures:none">GovernmentAffairsOhio@UHC.Com</span>](mailto:GovernmentAffairsOhio@UHC.Com)<span style="mso-ligatures:none">;
OH\_MCD\_PBM \<</span>[<span style="mso-ligatures:
none">OH\_MCD\_PBM@gainwelltechnologies.com</span>](mailto:OH_MCD_PBM@gainwelltechnologies.com)<span style="mso-ligatures:
none">\>;
</span>[<span style="mso-ligatures:none">OhioRISEPolicy@medicaid.ohio.gov</span>](mailto:OhioRISEPolicy@medicaid.ohio.gov)<span style="mso-ligatures:none">;
</span>[<span style="mso-ligatures:
none">ManagedCarePolicy@medicaid.ohio.gov</span>](mailto:ManagedCarePolicy@medicaid.ohio.gov)<span style="mso-ligatures:
none">  
**Cc:**
</span>[<span style="mso-ligatures:none">Kelsey.Hiegel@medicaid.ohio.gov</span>](mailto:Kelsey.Hiegel@medicaid.ohio.gov)<span style="mso-ligatures:none">;
</span>[<span style="mso-ligatures:none">Jessica.Hawk@medicaid.ohio.gov</span>](mailto:Jessica.Hawk@medicaid.ohio.gov)<span style="mso-ligatures:none">;
</span>[<span style="mso-ligatures:none">Sayeh.Shirvani@medicaid.ohio.gov</span>](mailto:Sayeh.Shirvani@medicaid.ohio.gov)<span style="mso-ligatures:none">;
</span>[<span style="mso-ligatures:
none">Jennifer.Mackim@medicaid.ohio.gov</span>](mailto:Jennifer.Mackim@medicaid.ohio.gov)<span style="mso-ligatures:
none">; Doughty, Yana
\<</span>[<span style="mso-ligatures:none">yana.doughty@medicaid.ohio.gov</span>](mailto:yana.doughty@medicaid.ohio.gov)<span style="mso-ligatures:none">\>;
Eckard, Sean
\<</span>[<span style="mso-ligatures:none">sean.eckard@medicaid.ohio.gov</span>](mailto:sean.eckard@medicaid.ohio.gov)<span style="mso-ligatures:none">\>;
Barger, Michelle \<</span>[<span style="mso-ligatures:
none">michelle.barger@medicaid.ohio.gov</span>](mailto:michelle.barger@medicaid.ohio.gov)<span style="mso-ligatures:
none">\>; Wharton, Donald
\<</span>[<span style="mso-ligatures:none">donald.wharton@medicaid.ohio.gov</span>](mailto:donald.wharton@medicaid.ohio.gov)<span style="mso-ligatures:none">\>;
</span>[<span style="mso-ligatures:
none">MEDICAID\_PHARMACY@medicaid.ohio.gov</span>](mailto:MEDICAID_PHARMACY@medicaid.ohio.gov)<span style="mso-ligatures:
none">;
</span>[<span style="mso-ligatures:none">MedicaidSPBM@medicaid.ohio.gov</span>](mailto:MedicaidSPBM@medicaid.ohio.gov)<span style="mso-ligatures:none">;
</span>[<span style="mso-ligatures:
none">Shirley.Williams@medicaid.ohio.gov</span>](mailto:Shirley.Williams@medicaid.ohio.gov)<span style="mso-ligatures:
none">;
</span>[<span style="mso-ligatures:none">Ryver.Penix@medicaid.ohio.gov</span>](mailto:Ryver.Penix@medicaid.ohio.gov)<span style="mso-ligatures:none">;
</span>[<span style="mso-ligatures:
none">Thomas.Papacostas@medicaid.ohio.gov</span>](mailto:Thomas.Papacostas@medicaid.ohio.gov)<span style="mso-ligatures:
none">;
</span>[<span style="mso-ligatures:none">Monica.Coleman@medicaid.ohio.gov</span>](mailto:Monica.Coleman@medicaid.ohio.gov)<span style="mso-ligatures:none">;
</span>[<span style="mso-ligatures:none">Taria.Jordan@medicaid.ohio.gov</span>](mailto:Taria.Jordan@medicaid.ohio.gov)<span style="mso-ligatures:none">  
**Subject:** Synagis Update</span>

</div>

</div>

 

<span style="font-size:14.0pt">Good afternoon,</span>

<span style="font-size:14.0pt"></span>

 

<span style="font-size:14.0pt">ODM has previously communicated that the
typical Synagis season was expected to conclude on March 31, 2023 and
there would be close monitoring and communication of noted RSV trends.
Due to the recent decline in RSV positivity rates, ODM is ending the
Synagis season effective February 15, 2023. </span>

<span style="font-size:14.0pt"></span>

 

<span style="font-size:14.0pt">Thank you for your assistance in caring
for our members. We will continue to keep communication open. Please
reply by **COB** **February 8, 2023** with receipt of this message and
confirmation that Synagis seasonal coverage is scheduled to end at your
MCE. </span>

<span style="font-size:14.0pt"></span>

 

<span style="font-size:14.0pt"></span>

 

<span style="font-size:14.0pt">Thank you.</span>

 

 

**<span style="font-family:&quot;Source Sans Pro&quot;,sans-serif;
color:#767171;mso-ligatures:none">Taria Jordan</span>**

<span style="font-size:10.0pt;font-family:&quot;Source Sans Pro&quot;,sans-serif;
color:#767171;mso-ligatures:none">Managed Care Policy </span>

<span style="font-size:10.0pt;font-family:&quot;Source Sans Pro&quot;,sans-serif;
color:#767171;mso-ligatures:none">The Ohio Department of Medicaid
</span>

<span style="font-size:10.0pt;font-family:&quot;Source Sans Pro&quot;,sans-serif;
color:#7F7F7F;mso-ligatures:none">Phone: 380-215-2139</span>

[<span style="font-size:10.0pt;font-family:&quot;Source Sans Pro&quot;,sans-serif;mso-ligatures:
none">Taria.Jordan@medicaid.ohio.gov</span>](mailto:Taria.Jordan@medicaid.ohio.gov)<span style="font-size:10.0pt;
font-family:&quot;Source Sans Pro&quot;,sans-serif;mso-ligatures:none">
</span>

<span style="font-size:10.0pt;font-family:&quot;Calibri Light&quot;,sans-serif;
mso-ligatures:none"></span>

 

<span style="font-size:10.0pt;font-family:&quot;Calibri Light&quot;,sans-serif;
mso-ligatures:none"><span class="image"></span></span><span style="mso-ligatures:none"></span>

 

</div>
